A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy-Reference-Cited by-同舟云学术

A novel 125I-labeled daunorubicin derivative for radionuclide-based cancer therapy

Published:2006-08 Issue:6 Volume:33 Page:773-783
ISSN:0969-8051
Container-title:Nuclear Medicine and Biology
language:en
Short-container-title:Nuclear Medicine and Biology

Author:

Ickenstein Ludger M.,Edwards Katarina,Sjöberg Stefan,Carlsson Jörgen,Gedda Lars

Publisher

Elsevier BV

Subject

Cancer Research,Radiology Nuclear Medicine and imaging,Molecular Medicine

Reference37 articles.

1. The current status of targeted radiotherapy in clinical practice;Gaze;Phys Med Biol,1996

2. Systemic radiotherapy — the new frontier;Order;Int J Radiat Oncol Biol Phys,1990

3. P-32 therapy of polycythemia: a review and reappraisal;Najean;Clin Nucl Med,1980

4. A comparison of the palliative effects of strontium-89 and external beam radiotherapy in metastatic prostate cancer;Quilty;Radiother Oncol,1994

5. Survival time and “cure” in papillary and follicular thyroid carcinoma with distant metastases: statistics following University of Michigan therapy;Beierwaltes;J Nucl Med,1982

Cited by 32 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Preparation and Evaluation of Thermosensitive Liposomes Encapsulating I-125-Labeled Doxorubicin Derivatives for Auger Electron Therapy;Molecules;2023-02-16

2. Nanostructures as Radionuclide Carriers in Auger Electron Therapy;Materials;2022-02-01

3. Principles and Applications of Auger-Electron Radionuclide Therapy;Nuclear Medicine and Molecular Imaging;2022

4. Advancements in the use of Auger electrons in science and medicine during the period 2015–2019;International Journal of Radiation Biology;2020-10-23

5. 165Er: A new candidate for Auger electron therapy and its possible cyclotron production from natural holmium targets;Applied Radiation and Isotopes;2020-05